Are you a new member? Sign up now
Login area
| Sign up
close
DACOGEN - 50mg - 1
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01BC08 | B | Decitabine - 50mg | 11542 | 33923/1 | DACOGEN | 50mg | 1 | Injectable lyophilised powder for solution | Infusion | Mersaco | BSP Pharmaceuticals SpA | Italy | 1,385,958 L.L | 2.44 | E2 | Janssen Cilag International NV | Belgium | 05/02/20 |
Drugs With Same Ingredients
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01BC08 | B | Decitabine - 50mg | 6497 | 167159/10 | DACOGEN | 50mg | 1 | Injectable lyophilised powder for solution | Infusion | Mersaco | BSP Pharmaceuticals SpA | Italy | 1,385,958 L.L | 2.44 | E2 | Janssen Pharmaceutica NV | Belgium | 05/02/20 | |
| L01BC08 | B | Decitabine - 50mg | 6497/945 | 167159/10 | DACOGEN | 50mg | 1 | Injectable lyophilised powder for solution | Infusion | Mersaco | BSP Pharmaceuticals SpA | Italy | 84,497,096 L.L | 2.44 | E2 | Janssen Pharmaceutica NV | Belgium | 05/02/20 | 0 |
| L01BC08 | B | Decitabine - 50mg | 11542/945 | 33923/1 | DACOGEN | 50mg | 1 | Injectable lyophilised powder for solution | Infusion | Mersaco | BSP Pharmaceuticals SpA | Italy | 84,497,096 L.L | 2.44 | E2 | Janssen Cilag International NV | Belgium | 05/02/20 | 0 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024